These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 27236285)
1. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin. Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285 [TBL] [Abstract][Full Text] [Related]
2. A Comparison of [ Hu Y; Liu G; Zhang H; Li Y; Gray BD; Pak KY; Choi HS; Cheng D; Shi H Mol Imaging Biol; 2018 Apr; 20(2):249-259. PubMed ID: 28785938 [TBL] [Abstract][Full Text] [Related]
3. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment. Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307 [TBL] [Abstract][Full Text] [Related]
4. Inflammation imaging of atherosclerosis in Apo-E-deficient mice using a (99m)Tc-labeled dual-domain cytokine ligand. Liu Z; Lerman LO; Tang H; Barber C; Wan L; Hui MM; Furenlid LR; Woolfenden JM Nucl Med Biol; 2014; 41(10):785-92. PubMed ID: 25195016 [TBL] [Abstract][Full Text] [Related]
5. In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences. Dimastromatteo J; Broisat A; Perret P; Ahmadi M; Boturyn D; Dumy P; Fagret D; Riou LM; Ghezzi C J Nucl Med; 2013 Aug; 54(8):1442-9. PubMed ID: 23719858 [TBL] [Abstract][Full Text] [Related]
6. Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis. Dietrich T; Berndorff D; Heinrich T; Hucko T; Stepina E; Hauff P; Dinkelborg LM; Atrott K; Giovannoni L; Neri D; Fleck E; Graf K; Menssen HD Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):228-37. PubMed ID: 25864530 [TBL] [Abstract][Full Text] [Related]
7. Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry. Chaudhry F; Kawai H; Johnson KW; Narula N; Shekhar A; Chaudhry F; Nakahara T; Tanimoto T; Kim D; Adapoe MKMY; Blankenberg FG; Mattis JA; Pak KY; Levy PD; Ozaki Y; Arbustini E; Strauss HW; Petrov A; Fuster V; Narula J J Am Coll Cardiol; 2020 Oct; 76(16):1862-1874. PubMed ID: 33059832 [TBL] [Abstract][Full Text] [Related]
8. Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis. Elvas F; Vangestel C; Rapic S; Verhaeghe J; Gray B; Pak K; Stroobants S; Staelens S; Wyffels L Mol Imaging Biol; 2015 Dec; 17(6):838-47. PubMed ID: 25896815 [TBL] [Abstract][Full Text] [Related]
9. The feasibility of imaging myocardial ischemic/reperfusion injury using (99m)Tc-labeled duramycin in a porcine model. Wang L; Wang F; Fang W; Johnson SE; Audi S; Zimmer M; Holly TA; Lee DC; Zhu B; Zhu H; Zhao M Nucl Med Biol; 2015 Feb; 42(2):198-204. PubMed ID: 25451214 [TBL] [Abstract][Full Text] [Related]
10. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages. Ayala-López W; Xia W; Varghese B; Low PS J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331 [TBL] [Abstract][Full Text] [Related]
11. Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. De Vos J; Mathijs I; Xavier C; Massa S; Wernery U; Bouwens L; Lahoutte T; Muyldermans S; Devoogdt N Mol Imaging Biol; 2014 Oct; 16(5):690-8. PubMed ID: 24687730 [TBL] [Abstract][Full Text] [Related]
12. [ Li Y; Liu C; Xu X; Lu X; Luo J; Gray B; Pak KY; Cheng J; Zhang Y Nucl Med Biol; 2018 Nov; 66():18-25. PubMed ID: 30170197 [TBL] [Abstract][Full Text] [Related]
15. Tan H; Abudupataer M; Qiu L; Mao W; Xiao J; Cheng D; Shi H Chem Biol Drug Des; 2021 Feb; 97(2):210-220. PubMed ID: 32881342 [TBL] [Abstract][Full Text] [Related]